An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment.
By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival.
How is CRISPR genome editing helping harness the power of immunotherapy?
Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.
Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.
In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.
How do you study cell division, without cells?